September 1, 2000 - Quintiles Transnational Corp. today announced the appointment of Neil MacAllister as CEO of Quintiles' commercialization unit, Innovex.

May 8, 2000 - CV Therapeutics, Inc. (Nasdaq: CVTX) and Innovex, a business unit of Quintiles Transnational Corp. (Nasdaq: QTRN), were recently honored.

January 10, 2000 - New structure enhances customer focus and efficiency; reflects industry business drivers